A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms

Disease Sites:

Not Available

Staging:

Phase I

Age Group:

Adults

Therapies:

Mol. targeted/Immunotherapy/Biologics

Drugs:

INCB160058

Principal Investigator(s):

Kishtagari, Ashwin

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

03-26-2025

Trial Type:

Treatment

Protocol ID:

VICC-DTHEM24055P

National Clinical Trial ID:

NCT06313593

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available